The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: NFL Philosophies, NBA Analytics, & MLB Storylines

Ep. 167

Show from 9/11/19


In this episode of Wharton Moneyball our hosts talk with the former Director of Basketball Research for the Milwaukee Bucks Seth Partnow. Who now covers NBA and Basketball analytics for The Athletic.They discuss with Seth on what production looks like from an analyst's view and will NBA teams defend the three point line closer. Next our hosts talk with former NFL 20 year NFL Executive, Joe Banner.on where the New England Patriots competitive edge comes from. Also have you ever wondered how NFL Executives build their NFL Team?


Guests:

Seth Partnow covers the NBA and basketball analytics for The Athletic. He resides in Milwaukee and was the Director of Basketball Research for the Milwaukee Bucks until this off season.

.

Follow him on Twitter @SethPartnow


Check out his articles https://theathletic.com/checkout/?plan_id=45&pc=offerended2 


Joe Banner is a former NFL 20 year NFL Executive. He was the President of the Philadelphia Eagles and later the CEO of the Cleveland Browns. He was also an ESPN analyst.


Follow him on Twitter @JoeBanner13.



More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.